Ubiquitous Nature of Distal Athero/Thromboembolic Events during Lower Extremity Atherectomy Procedures Involving the Superficial Femoral Artery

Abstract

This study aims to evaluate occurrence, size, composition, and clinical significance of embolized debris during superficial femoral artery atherectomy using all commercially available atherectomy devices.

Distal athero/thromboembolic events (DATE) are a universal phenomenon in lower extremity atherectomy procedures (LEAPs) due to the sheer volume of atheroma and the thrombus burden in peripheral arterial disease. Some of these events can be clinically significant.

We prospectively gathered clinical and histopathological data on all commercially available atherectomy devices by using embolic protection devices (EPD) in every case. After intervention, the contents of EPD were examined both microscopically and macroscopically.

Data from 59 consecutive patients undergoing LEAP were analyzed. DATE occurred 100% of the time. The composition of particulate debris varied with the device used. Grossly visible agglomerated debris was captured by the filter in the majority of patients 54/59 (91.5%). Clinically significant debris, defined by the Preventing Lower Extremity Distal Embolization Using Embolic Filter Protection registry as particle diameter > 0.2 cm, was found in 33/59 (56%) patients. The size of captured debris particles ranged from 0.1 to 2.4 mm.

While DATE occurred in all patients, clinically significant DATE occurred in 56% patients undergoing LEAP regardless of the atherectomy device. In spite of a large fraction of the clinically significant debris occurring on our routine dual antiplatelet regimen, no patient suffered an amputation. Although DATE was prevented by the use of EPD in all 59 cases, more data are needed to determine whether the use of EPD translates into a long-term clinical benefit. Use of EPD and optimal thromboprophylaxis should be considered in patients, especially in the setting of compromised distal runoff.

Keywords

cardiac catheterization - peripheral arterial thromboembolism - atherectomy - endovascular procedures

• References

• 1 Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 2004; 25 (14) 1197-1207
• 2 Schoenhagen P, Ziada KM, Vince DG, Nissen SE, Tuzcu EM. Arterial remodeling and coronary artery disease: the concept of “dilated” versus “obstructive” coronary atherosclerosis. J Am Coll Cardiol 2001; 38 (2) 297-306
• 3 Shammas NW, Dippel EJ, Coiner D, Shammas GA, Jerin M, Kumar A. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther 2008; 15 (3) 270-276
• 4 Tarricone A, Ali Z, Rajamanickam A , et al. Histopathological Evidence of Adventitial or Medial Injury Is a Strong Predictor of Restenosis During Directional Atherectomy for Peripheral Artery Disease. J Endovasc Ther 2015; 22 (5) 712-715
• 5 Becker GJ, McClenny TE, Kovacs ME, Raabe RD, Katzen BT. The importance of increasing public and physician awareness of peripheral arterial disease. J Vasc Interv Radiol 2002; 13 (1) 7-11
• 6 Criqui MH, Langer RD, Fronek A , et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326 (6) 381-386
• 7 Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993; 270 (4) 487-489
• 8 Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology 1989; 170 (3 Pt 2) 921-940
• 9 McDermott JC, Crummy AB. Complications of angioplasty. Semin Intervent Radiol 1994; 11: 145-149
• 10 Freeman HJ, Rundback JH. Embolic protection in femoro-popliteal artery intervention. Endovascular Today, 2006. Available at: http://evtoday.com/pdfs/EVT1006_06.pdf . Accessed October 2006
• 11 Casserly IP, Abou-Chebl A, Fathi RB , et al. Slow-flow phenomenon during carotid artery intervention with embolic protection devices: predictors and clinical outcome. J Am Coll Cardiol 2005; 46 (8) 1466-1472
• 12 Bartorelli AL, Koh TH, Di Pede F , et al. Distal embolic protection during percutaneous coronary intervention in patients with acute coronary syndromes: the RUBY study. Acute Card Care 2006; 8 (3) 148-154
• 13 Suri R, Wholey MH, Postoak D, Hagino RT, Toursarkissian B. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv 2006; 67 (3) 417-422
• 14 Kastrup A, Nägele T, Gröschel K , et al. Incidence of new brain lesions after carotid stenting with and without cerebral protection. Stroke 2006; 37 (9) 2312-2316
• 15 van Gaal WJ, Choudhury RP, Porto I , et al. Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol 2007; 99 (5) 603-606
• 16 Lam RC, Shah S, Faries PL, McKinsey JF, Kent KC, Morrissey NJ. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg 2007; 46 (6) 1155-1159
• 17 McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA ; DEFINITIVE LE Investigators. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv 2014; 7 (8) 923-933
• 18 Shammas NW, Shammas GA, Dippel EJ, Jerin M, Shammas WJ. Predictors of distal embolization in peripheral percutaneous interventions: a report from a large peripheral vascular registry. J Invasive Cardiol 2009; 21 (12) 628-631
• 19 Kaid KA, Gopinathapillai R, Qian F, Salvaji M, Wasty N, Cohen M. Analysis of particulate debris after superficial femoral artery atherectomy. J Invasive Cardiol 2009; 21 (1) 7-10
• 20 Shammas NW, Coiner D, Shammas GA, Dippel EJ, Christensen L, Jerin M. Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. J Vasc Interv Radiol 2011; 22 (9) 1223-1228
• 21 Roberts D, Niazi K, Miller W , et al; DEFINITIVE Ca⁺⁺ Investigators. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca⁺⁺ trial. Catheter Cardiovasc Interv 2014; 84 (2) 236-244
• 22 Shammas NW, Coiner D, Shammas GA, Christensen L, Dippel EJ, Jerin M. Distal embolic event protection using excimer laser ablation in peripheral vascular interventions: results of the DEEP EMBOLI registry. J Endovasc Ther 2009; 16 (2) 197-202